What is the Enbio Holdings Inc. stock price forecast?

Enbio Holdings Inc. is currently trading at ¥734. View real-time AI analysis on Alpha Lenz.

What is Enbio Holdings Inc. insider trading activity?

View the latest insider trading data for Enbio Holdings Inc. on Alpha Lenz.

What is Enbio Holdings Inc.'s P/E ratio?

Enbio Holdings Inc.'s P/E ratio is 13.1.

Enbio Holdings Inc.

JPX · 6092

¥734+7(+0.96%)Market closed

Ask about Enbio Holdings Inc.'s future dividend policy...

Alpha Chat Insight

“Enbio Holdings Inc. trades at a P/E of 13.1 (undervalued) with modest ROE of 5.1%.”

Ask for details →

Company Overview

Enbio Holdings Inc. is a company involved in the design and development of innovative surface treatment technologies that enhance the performance and lifespan of a range of products. Specializing in the creation of advanced materials, Enbio Holdings Inc. pursues applications across various industries, including aerospace, automotive, and the medical sector. Through its proprietary processes, the company aims to improve the durability, efficiency, and functionality of components, enabling manufacturers to produce more reliable and long-lasting products. Founded on a commitment to technological advancement and sustainability, Enbio Holdings Inc. has established a strong presence in the market as a provider of cutting-edge material solutions, playing a significant role in enhancing industry standards and promoting environmental responsibility.

CEOMr. Yoshikazu Nakamura

Websitehttps://enbio-holdings.com

SectorIndustrials

IndustrySpecialty Business Services

Employees101

Company Statistics

FY 2025

Profile

¥5,944,588,196Market Cap

¥10,668,079,000Revenue

0.00Shares Out

101Employees

Margins

24.87%Gross

12.34%EBITDA

7.87%Operating

6.58%Pre-Tax

3.94%Net

Valuation

13.13P/E

0.65P/B

0.56EV/Sales

9.75EV/EBITDA

-4.11P/FCF

Growth (CAGR)

5.88%Rev 3Yr

7.57%Rev 5Yr

-11.94%Op Inc 3Yr

4.48%Op Inc 5Yr

-15.92%Net Inc 3Yr

-4.61%Net Inc 5Yr

Returns

2.07%ROA

5.13%ROE

4.16%ROIC

Financial Health

¥3,293,050,000Cash & Cash Equivalents

¥8,671,534,000Net Debt

129.62%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Enbio Holdings Inc. trades at a P/E of 13.1 (undervalued) with modest ROE of 5.1%.”

Ask for details →

Frequently Asked Questions

Enbio Holdings Inc. (ticker: 6092) is a company listed on JPX in the Industrials sector (Specialty Business Services). It has approximately 101 employees. Market cap is $5.9B.

The current price is 734 with a P/E ratio of 13.13x and P/B of 0.65x.

ROE is 5.13% and operating margin is 7.87%. Annual revenue is $10.7B.